Disparity between angiographic regression and clinical event rates with hydrophobic statins.
Ichihara
Kazuo
K
Department of Pharmacology, Hokkaido College of Pharmacy, 7-1 Katsuraoka, Otaru 047-0264, Japan. ichihara1@hokuyakudai.ac.jp
Satoh
Kumi
K
D000818:Animals; D002986:Clinical Trials as Topic; D006801:Humans; D057927:Hydrophobic and Hydrophilic Interactions; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000188:drug therapy*; D008798:Mevalonic Acid / Q000378:metabolism; D009200:Myocardial Contraction / Q000187:drug effects*; D015398:Signal Transduction / Q000187:drug effects; D014451:Ubiquinone / Q000096:biosynthesis
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D014451:Ubiquinone; D008798:Mevalonic Acid